Italian health cost curbs, budget moves sought

15 July 2001

The procurator-general of Italy's Court of Accounts, Vincenzo Apicella,has urged the country's new government to risk unpopularity and bring health care spending under control "with gradual firmness."

Reviewing Italy's financial situation in 2000, and looking at this year's prospects, he said that health care costs now are far higher than in the past, at both national and regional level. He called for economizing on services, "accepting limits, making economic sacrifices and stabilizing the level of health care support."

Meantime, Italy's regional health funds have called for a revamp of the health care budget and the way health service funds are divided, especially in light of 2001's forecast 16,000 billion lire ($7.00 billion) deficit. The funds want more freedom to shape their own budget priorities and, in particular, a review of last August's agreement with central government on health spending.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight